Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...

A Big Chalk Analytics survey of 4,511 U.S. shoppers in spring of 2025 showed that 11.2% of adults are using GLP-1 drugs, and ...

Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...

CHICAGO — Tariffs, the rise of GLP-1 medications and concerns about ultra-processed foods (UPFs) remain some of the major ...

Longer treatment duration, not having diabetes, and using semaglutide are among the factors linked to better weight reduction over 12 months.

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

For patients with idiopathic intracranial hypertension, GLP-1 RA treatment is associated with improved clinical outcomes.

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

GLP-1 agonists and dual agonists can cause hypoglycemia, nausea, and more. But there are ways to lessen the side effects, so you can keep taking the medication.